amuvatinib Search Results


91
MedChemExpress amuvatinib
Amuvatinib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/amuvatinib/product/MedChemExpress
Average 91 stars, based on 1 article reviews
amuvatinib - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier

93
Selleck Chemicals amuvatinib
Amuvatinib, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/amuvatinib/product/Selleck Chemicals
Average 93 stars, based on 1 article reviews
amuvatinib - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Janssen amuvatinib mutant c-kit, pdgfrα, flt3, c-met and c-ret
TKIs are currently either FDA approved in cancer or under clinical or pre-clinical investigation for NDDs.
Amuvatinib Mutant C Kit, Pdgfrα, Flt3, C Met And C Ret, supplied by Janssen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/amuvatinib mutant c-kit, pdgfrα, flt3, c-met and c-ret/product/Janssen
Average 90 stars, based on 1 article reviews
amuvatinib mutant c-kit, pdgfrα, flt3, c-met and c-ret - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Astex Inc amuvatinib (13)
TKIs are currently either FDA approved in cancer or under clinical or pre-clinical investigation for NDDs.
Amuvatinib (13), supplied by Astex Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/amuvatinib (13)/product/Astex Inc
Average 90 stars, based on 1 article reviews
amuvatinib (13) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
SuperGen Inc tam inhibitor mp470
TKIs are currently either FDA approved in cancer or under clinical or pre-clinical investigation for NDDs.
Tam Inhibitor Mp470, supplied by SuperGen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tam inhibitor mp470/product/SuperGen Inc
Average 90 stars, based on 1 article reviews
tam inhibitor mp470 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Astex Inc amuvatinib
TKIs are currently either FDA approved in cancer or under clinical or pre-clinical investigation for NDDs.
Amuvatinib, supplied by Astex Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/amuvatinib/product/Astex Inc
Average 90 stars, based on 1 article reviews
amuvatinib - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Janssen amuvatinib
TKIs are currently either FDA approved in cancer or under clinical or pre-clinical investigation for NDDs.
Amuvatinib, supplied by Janssen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/amuvatinib/product/Janssen
Average 90 stars, based on 1 article reviews
amuvatinib - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
MultiTarget Pharmaceuticals amuvatinib (mp–470)
TKIs are currently either FDA approved in cancer or under clinical or pre-clinical investigation for NDDs.
Amuvatinib (Mp–470), supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/amuvatinib (mp–470)/product/MultiTarget Pharmaceuticals
Average 90 stars, based on 1 article reviews
amuvatinib (mp–470) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Astex Inc in vitro permeability of amuvatinib
TKIs are currently either FDA approved in cancer or under clinical or pre-clinical investigation for NDDs.
In Vitro Permeability Of Amuvatinib, supplied by Astex Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/in vitro permeability of amuvatinib/product/Astex Inc
Average 90 stars, based on 1 article reviews
in vitro permeability of amuvatinib - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Astex Inc amuvatinib lsc
TKIs are currently either FDA approved in cancer or under clinical or pre-clinical investigation for NDDs.
Amuvatinib Lsc, supplied by Astex Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/amuvatinib lsc/product/Astex Inc
Average 90 stars, based on 1 article reviews
amuvatinib lsc - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


TKIs are currently either FDA approved in cancer or under clinical or pre-clinical investigation for NDDs.

Journal: Frontiers in Dementia

Article Title: Tyrosine kinases: multifaceted receptors at the intersection of several neurodegenerative disease-associated processes

doi: 10.3389/frdem.2024.1458038

Figure Lengend Snippet: TKIs are currently either FDA approved in cancer or under clinical or pre-clinical investigation for NDDs.

Article Snippet: Amuvatinib , Mutant c-Kit, PDGFRα, Flt3, c-Met and c-Ret (2021) , metastatic non-small cell lung cancer (NSCC) , Janssen Biotech (oral).

Techniques: Mutagenesis

TKIs are currently either FDA approved in cancer or under clinical or pre-clinical investigation for NDDs.

Journal: Frontiers in Dementia

Article Title: Tyrosine kinases: multifaceted receptors at the intersection of several neurodegenerative disease-associated processes

doi: 10.3389/frdem.2024.1458038

Figure Lengend Snippet: TKIs are currently either FDA approved in cancer or under clinical or pre-clinical investigation for NDDs.

Article Snippet: Amuvatinib , Mutant c-Kit, PDGFRα, Flt3, c-Met and c-Ret (2021) , metastatic non-small cell lung cancer (NSCC) , Janssen Biotech (oral).

Techniques: Mutagenesis